Company Filing History:
1 out of 56 
1 out of 87 
1 out of 1 Years Active: 2025
Title: Brandon Wilder: Innovator in Malaria Vaccine Development
Introduction
Brandon Wilder is a notable inventor based in Seattle, WA (US). He has made significant contributions to the field of biomedical research, particularly in the development of vaccines for malaria. His innovative work has the potential to impact global health positively.
Latest Patents
Brandon Wilder holds a patent for "Plasmodium sporozoite NPDP peptides as vaccine and target novel malaria vaccines and antibodies binding to." This invention provides a fragment of the plasmodium circumsporozoite protein, which can be utilized in malaria vaccines. The patent also includes nucleic acids encoding this protein fragment and compositions that comprise it. Additionally, the antibodies developed through this invention specifically bind to sporozoites, offering potential applications in the treatment and prevention of malaria.
Career Highlights
Throughout his career, Brandon has worked with esteemed institutions such as the Institute for Research in Biomedicine and Seattle Children's Hospital. His experience in these organizations has allowed him to advance his research and contribute to significant medical breakthroughs.
Collaborations
Brandon has collaborated with notable professionals in his field, including Antonio Lanzavecchia and Joshua Hoong Yu Tan. These partnerships have enriched his research and fostered innovation in malaria vaccine development.
Conclusion
Brandon Wilder's work exemplifies the intersection of innovation and public health. His contributions to malaria vaccine research are vital in the ongoing fight against this disease. His patent and collaborations highlight his commitment to advancing medical science and improving global health outcomes.